24 minute read
Birthdays – January
In March 2022, the Nominating Committee consisting of Dr. Millie Willy, Past President as Chair, Dr. Tony Zacharek as President and Dr. Tiffany Kim as President-Elect, asked the SCMS Board to consider amending the Bylaws to allow all delegates and alternates to have a vote. It was the Nominating Committee’s opinion that if we have active and retired members giving of their time and serving the SCMS, they should be entitled to a vote. New members to the Board generally start as an alternate delegate as they learn the Board process. Past presidents serving as alternate delegates offer a wealth of history and experience on SCMS issues. Per the Bylaws, officers and directors have voting privileges. Each June, the officers and directors vote for three delegates who are not already serving in a voting position as an officer or director to be voting members of the Board. Any additional delegates and alternate delegates do not have a vote. Alternate delegates include past presidents who want to stay involved on the Board. SCMS quorum is one-third of voting Board members. After thoughtful consideration, the Board voted at the September 18, 2022, Meeting to approve an Amendment to the Bylaws. The relevant sections of the Bylaws follow, with text to be removed in red-strikethrough, and text to be added highlighted yellow:
CHAPTER XIII DUTIES OF OFFICERS
Advertisement
Section 6. DELEGATES AND ALTERNATE DELEGATES. The delegates, and in their absence or disability, the alternate delegates, shall attend and faithfully represent the members of this Society in the House of Delegates of the Michigan State Medical Society, and shall make a report of the proceedings of the House of Delegates at the next following regular meeting
JANUARY BIRTHDAYS
Jamal U. Akbar MD Wasef Al-Khateeb MD Sarosh Anwar MD Edward Austin MD Steve Balian MD Alia M. Bapary MD John K. Bartnik MD Ronald A. Bays MD Abbas Bekhrad MD Robert L. Borenitsch DO Tony Bourdkane MD Gary A. Brooks MD Paul B. Bry MD Lowell A. Butman MD Marcello L. Caso MD Doris D. Cataquiz MD Bryon C. Chamberlain MD Moonyoung S. Chung MD Louis L. Constan MD Elvira M. Dawis MD Angie Lynn F. Domingo MD Patrick A. Fewins Student Rica A. Generoso Student Steven D. Hale MD Gabriel S. Hamawi DPM Leatha B. Hayes DO Gregory C. Hazen MD Alicia Hoban MD Ali E. Ibrahim MD Mohammad Jafferany MD Shakeel M. Jamal MD Ashley Jones MD Roger N. Kahn MD Sreevastav T. Kalangi MD Nadim Kanaan MD Charles A. Keane MD Mohammad Yahya Khan MD Young H. Kim MD Haley Kopkau Student Ayushi A. Kumar Student Menelito D. Lilagan DO Marko Lubardic Student Mark R. Ludka MD Hamza Malik MD Ben R. Mayne MD Matthew F. McDowell DO Vickie B. Mello DO Babu L. Nahata MD Sunil P. Pandit MD Alan I. Rebenstock MD S. Sethu K. Reddy MD Emily Ridge Student Douglas J. Saylor MD Susan K. Schmiege MD
Happy Special Birthday! Michael L. Schultz MD Maliha N. Shaikh MD Jacquelyn G. Small DO F. Ann Sobell Student Shravani Sripathi MD Molly Stanford Student Angelika A. Urbaniak MD Matthew N. Vartanian MD Venkatramana R. Vattipally MD Daniel J. Wechter MD Arno W. Weiss, Jr. MD
CHAPTER XIV BOARD OF DIRECTORS
Section 1. The Board of Directors shall consist of the president, president-elect, the immediate past president, the secretary, the treasurer, the editor of the Bulletin, six directors to be elected from among the membership, and three members which shall be elected from the pool of MSMS Delegates the duly elected delegates and alternate delegates. The current president shall act as chair of the Board. The secretary of this Society shall act as secretary of the Board. The Past President will remain on the SCMS Board whether s/ he retires or remains in active practice. The Board will appoint a retiree representative to the Board to serve a one (1) year term. The Board of Directors shall have the power to appoint resident representative(s) and medical student(s) for terms to be determined at their discretion to serve on the Board. The resident representative(s) and medical student(s) shall not be subject to Section 2 of Chapter XIV herein requiring attendance at fifty percent (50%) of Board meetings, but the resident representative(s) and medical student(s) shall make every effort to attend as many meetings as possible so as to effectively represent their peers. The retiree representative, resident representative(s) and medical student(s) will be non-voting members of the Board.
In accordance with the Bylaws and SCMS policy, the proposed Bylaws Amendment will be published in two issues of The Bulletin, and brought before the membership for a vote to approve at the next occurring Membership Meeting on Tuesday, January 17, 2023.
If any member has questions or concerns about the proposed Bylaws Amendment, please email Joan Cramer at jmcramer@sbcglobal.net by December 31, 2022.
The SCMS Board of Directors formed an Ad Hoc Committee of Drs. Chris Allen, Lou Constan, Tiffany Kim, Miriam Schteingart and Tony Zacharek to develop the Mission, Vision and Values Statements of the SCMS. The Committee met on Tuesday, August 16, 2022, via Zoom. The purpose of the Committee was to establish the Mission, Vision and Values Statements of the SCMS based on prior Board discussion. • The MISSION STATEMENT communicates the purpose of the organization. • The VISION STATEMENT provides insight into what the organization hopes to achieve or become in the future. • The VALUES STATEMENT reflects the organization’s core principles and ethics. The Committee’s recommendations were approved by the SCMS Board of Directors at their meeting on Tuesday, September 18, 2022.
MISSION STATEMENT
• Bringing physicians together for the common good
VISION STATEMENT
• We aim to improve the lives of physicians and the patients
we serve
Service Advocacy Genuine Health Inclusive Networking Always Learning We Lead
In accordance with SCMS policy, the proposed Mission, Vision and Values Statements will be published in two issues of The Bulletin, and then brought before the membership for a vote to approve at the next occurring Membership Meeting on Tuesday, January 17, 2023.
If any member has questions or concerns about the proposed Mission, Vision and Values Statements, please email Joan Cramer at jmcramer@sbcglobal.net by December 31, 2022.
120 Years of Serving the Residents of Saginaw County!
www.SaginawCountyMS.com
Renewing Your Medical License in 2023? What You Need to Know!
As a reminder, physician license renewals are quickly approaching. One third of licensed osteopathic and allopathic physicians are required to renew their three-year license every year. Please see the information below to assist with the process and requirements.
CHECK YOUR LICENSE NOW
MICHIGAN MEDICAL DOCTOR (MD) LICENSING GUIDE
(revised 9/28/2022)
MICHIGAN OSTEOPATHIC PHYSICIAN (DO) LICENSING
GUIDE (revised 9/28/2022)
BUREAU OF PROFESSIONAL LICENSING MEDICINE FAQs
In October of 2021, the Bureau of Professional Licensing (BPL) migrated over 700,000 licenses to a new licensing platform called MiPLUS. The benefits of MiPLUS include an online account and an electronic application. As soon as your license is issued or renewed, you will receive an electronic copy of your license via email. Electronic copies of licenses are also stored in your MiPLUS account and can be accessed at any time. Due to the functionality of MiPLUS, paper copies of
licenses will no longer be automatically mailed upon
issuance or renewal. Instead, licensees will be able to choose if they’d prefer to have a copy of their license mailed to them during the application or renewal process. Licensees benefit because an electronic copy is immediately available to them. To access your MiPLUS account, please visit www.michigan. gov/miplus. If you have any questions, please contact bplhelp@michigan.gov or 517-241-0199.
Every 3 Years
Medical doctors are required to complete 150 hours of continuing education of which a minimum 75 hours of the required 150 hours must be earned in courses or programs designated as Category 1 programs. The remaining 75 hours may comprise of Category 1 and 2 credits within the maximums allowed. Click HERE for a brief description of each category and the number of allowable hours and acceptable documentation. Osteopathic physicians are required to complete a minimum of 60 hours in Category 1. Click HERE for a brief description of each category and the number of allowable hours and acceptable documentation.
Required CME
Within the 150 hours of continuing medical education, a minimum of one hour of continuing education must be in the area of medical ethics and three hours must be in the area of pain and symptom management (with at least one of the three hours specifically on controlled substance prescribing). In addition, effective June 2022, a minimum of three hours every three-year relicensing cycle is required in Implicit Bias education. Renewals in January 2023 need one hour; renewals in 2024 need two hours; and renewals in 2025 need three hours. Then after, every three-year renewal cycle will need
to report three hours. Hours earned after June 2021 can
be used.
One-Time Requirements
Effective January 4, 2019, LARA announced a one-time
Opioids and Controlled Substances Awareness Training Standards for Prescribers and Dispensers of Controlled
Substances. This is separate from continuing education for an individual seeking a controlled substance license or who is licensed to prescribe or dispense controlled substances. Also, separate from continuing medical education requirements, physicians must complete a one-time human trafficking requirement.
Recognition of Hours Worked Responding During the COVID-19 Emergency
Include your hours claimed on behalf of Executive Orders 2020-13, 2020-49 and 2020-82 which stated that LARA may recognize hours worked responding to the COVID-19 pandemic as hours toward continuing education courses or programs required for licensure. These orders were in effect from March 17-June 9, 2020. Physician members were directed to submit hours to the MSMS Education Department for processing.
Renewal Grace Period
There is a 60-day grace period in which you may renew your license without having to go through the relicensure process. If you renew during the 60-day grace period, there is an additional $20 late fee when you renew your license.
However, if your license is not renewed within the 60-day grace period after your expiration date, your
license will lapse. The expiration date will reflect the original expiration date - it will not include the grace period. For example: If your license expires January 31, you have until April 1 to pay your renewal fee. If you do not renew by April 1, the end of the 60-day grace period, your license is considered lapsed as of January 31. Please note that when your license
lapses, you can no longer practice your profession, nor can
Healthcare Marketing &
Put creativity to work for your practice!
Helping practices create and design a wide range of professional visual materials for healthcare marketing initiatives
LOGOS & BRAND ASSETS | PRINT MATERIALS FORMS/PATIENT FOLDERS | PRESENTATIONS TRADESHOW & PROMOTION MATERIALS DIGITAL AD GRAPHICS | WEBSITE DESIGN Proud to be the Designer for the Saginaw County Medical Society
Lori Krygier | Graphic Designer 989.239.1056 | lkrygier@charter.net lorikrygier.com
• Comprehensive Eye Exam • Custom Lasek Surgery • No-Stitch Cataract Surgery • Macular Degeneration Treatment • Oculoplastic Surgery • Cornea Treatment • Low Vision • Optical Boutique • Retinal Surgery
5161 Cardinal Park Drive, Saginaw, MI 48604 1601 Marquette, Suite 1, Bay City, MI 48706 www.anderseneye.com 989.797.2400
you identify yourself as a licensed individual. If you have not completed your CME requirements by your license renewal date, you are allowed to use this grace period to complete those credits. Do not submit your renewal prior to completing your CME but do not exceed the 60-day period.
Continuing Medical Education Waivers
The Board of Medicine may waive the continuing medical education requirements for a license renewal if the failure of the license was due to the licensee’s disability, military service, absence from the continental United States, or a circumstance beyond the control of the licensee which the board considers sufficient. To request a waiver, a written request must be submitted by mail to Bureau of Professional Licensing, Attn: Board of Medicine, P.O. Box 30670, Lansing, MI 48909, or by email to BPLHelp@michigan.gov and will need to include supporting documentation for the reason for the waiver. A waiver cannot be requested after an application for renewal has been submitted. The board cannot prospectively waive continuing education requirements.
Renewing Your License
Physicians will be sent a renewal notification to both your mailing and email address on record approximately 90 days prior to the expiration date of your license. You will not be able to renew before that time. Remember to notify LARA of any address change by submitting a MiPLUS modification.
LARA states that it is the providers responsibility as a licensed health professional to renew your license on time. Failure to receive the renewal postcard, email notification, or to notify LARA of an address change does not exempt
physicians from renewing their license on time. To renew your license, go online to your MiPLUS account at www.michigan.gov/MiPLUS. Renewal payments can be taken by using a debit or credit card containing a Visa, MasterCard, American Express or Discover logo.
Online CME Courses Online CME courses including the required content areas are available here>>
Details on the required and one-time CME are available here>>
For more information or for questions on Online CME Courses, please contact Brenda Marenich or Rebecca Blake at MSMS.
Read previous issues of The Bulletin at www.SaginawCountyMS.com under the Bulletin tab
November 4, 2022 November 4, 2022
1. I do not currently electronically prescribe. Which software should I use? 1. I do not currently electronically prescribe. Which software should I use?
MCL 333.17754a will soon require all prescribers to electronically transmit all controlled and non-controlled substance prescriptions unless otherwise exempt under the statute (see question 3 below controlled substance prescriptions unless otherwise exempt under the statute for exemptions). (see question 3 below for exemptions). The department does not recommend specific software. Please refer to MCL 333.17754a(1) and (2)
The department does not recommend specific software. Please refer to MCL 333.17754a(1) and (2) for guidance on the type of software that can be used. You may also want to contact your professional for guidance on the type of software that can be used. You may also want to contact your professional association for guidance. Additionally, the Drug Enforcement Administration has approved various association for guidance. Additionally, the Drug Enforcement Administration has entities to provide the certification of electronic prescribing systems. approved various entities to provide the certification of electronic prescribing systems.
2. When does the electronic prescribing requirement go into effect?2. When does the electronic prescribing requirement go into effect?
The Bureau of Professional Licensing’s (BPL) enforcement of the electronic prescribing standard will coincide with the Centers for Medicare & Medicaid Services' (CMS) enforcement schedule for Part D coincide with the Centers for Medicare & Medicaid Services' (CMS) enforcement schedule for Part D prescription drug programs. As a result, BPL will initiate enforcement of Michigan’s new electronic prescription drug programs. As a result, BPL will initiate enforcement of Michigan’s new electronic prescribing standard on January 1, 2023. prescribing standard on January 1, 2023.
3. Are there any exemptions to the law?3. Are there any exemptions to the law?
MCL 333.17754a(5) provides a number of exemptions to the law. In addition, BPL will soon be accepting applications for a waiver of the electronic prescribing requirements. Listed exemptions in accepting applications for a waiver of the electronic prescribing requirements. Listed exemptions in MCL 333.17754a(5) include:
MCL 333.17754a(5) include: (a) If the prescription is issued by a prescriber who is a veterinarian licensed under Article 15 of (a) If the prescription is issued by a prescriber who is a veterinarian licensed under Article 15 of the Public Health Code. the Public Health Code. (b) If the prescription is issued under a circumstance in which electronic transmission is not (b) If the prescription is issued under a circumstance in which electronic transmission is not available due to a temporary technological or electrical failure. available due to a temporary technological or electrical failure. (c) If the prescription is issued by a prescriber who has received a waiver from the department (c) If the prescription is issued by a prescriber who has received a waiver from the department under MCL 333.17754a(7).under MCL 333.17754a(7). (d) If the prescription is issued by a prescriber who reasonably believes that electronically (d) If the prescription is issued by a prescriber who reasonably believes that electronically transmitting the prescription would make it impractical for the patient who is the subject of the transmitting the prescription would make it impractical for the patient who is the subject of the prescription to obtain the prescription drug in a timely manner and that the delay would adversely prescription to obtain the prescription drug in a timely manner and that the delay would adversely affect the patient's medical condition. A prescriber who does not electronically transmit a affect the patient's medical condition. A prescriber who does not electronically transmit a prescription under this subdivision shall document the specific reason for his or her belief that the prescription under this subdivision shall document the specific reason for his or her belief that the delay would adversely affect the patient's medical condition. delay would adversely affect the patient's medical condition. (e) If the prescription is orally prescribed under section 7333(3) or (4).(e) If the prescription is orally prescribed under section 7333(3) or (4). (f) If the prescription is issued by a prescriber to be dispensed outside of this state. (f) If the prescription is issued by a prescriber to be dispensed outside of this state. (g) If the prescription is issued by a prescriber who is located outside of this state to be dispensed (g) If the prescription is issued by a prescriber who is located outside of this state to be dispensed by a pharmacy located inside of this state. by a pharmacy located inside of this state.
(h) If the prescription is issued and dispensed in the same health care facility and the individual for whom the prescription is issued uses the drug exclusively in the health care facility. As used in this subdivision, "health care facility" includes, but is not limited to, any of the following: (i) A hospital. (ii) A hospice. (iii) A dialysis treatment clinic. (iv) A freestanding surgical outpatient facility. (v) A skilled nursing facility. (vi) A long-term care facility that provides rehabilitative, restorative, or ongoing skilled nursing care to an individual who is in need of assistance with activities of daily living. (i) If the prescription contains content that is not supported by the National Council for Prescription Drug Programs Prescriber/Pharmacist Interface SCRIPT Standard. (j) If the prescription is for a drug for which the FDA requires the prescription to contain content that cannot be transmitted electronically. (k) If the prescription is issued under circumstances in which the prescriber is not required to include on the prescription a name of a patient for whom the prescription is issued including, but not limited to, a prescription issued under section 5110. (l) If the prescription is issued by a prescriber who is prescribing the drug under a research protocol. (m) If the prescription is dispensed by a dispensing prescriber. (n) If the prescription is for a dialysis-related drug that is administered as part of or incident to a home-based dialysis treatment.
4. Are orally prescribed prescriptions still allowed?
Pursuant to MCL 333.17754a(5), an orally prescribed prescription for a controlled substance issued pursuant to MCL 333.7333(3) or (4) is exempt from the electronic prescribing requirement.
5. I am retired, have left active practice, or do not practice in Michigan at this time. Am I required to electronically prescribe?
MCL 333.17754a will soon require all prescribers, even those retired or not in active practice, to electronically transmit all controlled and non-controlled substance prescriptions unless otherwise exempt under the statute. In addition, BPL is accepting applications for a waiver of the electronic prescribing requirements.
6. I do not intend to prescribe, but I wish to maintain my license. Do I need to do anything to maintain my license under this new law?
A prescriber who does not plan to prescribe is not required to take any further action under the electronic prescribing law in order to maintain their license. The law will only apply when writing prescriptions.
7. What is involved in the rulemaking process for the electronic prescribing rules?
After the filing of a Request for Rulemaking, the rule set is considered to be open. During the rule promulgation process, BPL hosts rules committee work group meetings where the public is invited to participate in the creation of the revised draft. Further, as part of the promulgation process, rules sets are sent to a public hearing where the public is encouraged to make specific comments about the Page 2 of 3
draft before it is sent to the legislature for review and final promulgation. Both the Pharmacy General rules and the Controlled Substance rules have completed the promulgation process.
8. I am unable to meet the electronic prescribing requirements. How do I obtain a waiver?
BPL has created a form that can be used by prescribers who may fall into one of the narrow categories in the law and wish to apply for a waiver of the electronic prescribing requirements of MCL 333.17754a. The form can be found on our website. If you would like to apply for a waiver, complete the form and email it to bpldata@michigan.gov or mail it to PO Box 30670, Lansing, MI 48909. Please note that requests sent by postal mail will take longer to process than requests sent by email.
9. I already have an electronic prescribing system. Do I need to get a new system?
If you are already electronically prescribing, and your current system complies with the requirements in MCL 333.17754a(1) and (2), you do not need to change systems.
10. How does this affect veterinary prescriptions?
The electronic prescribing requirements do not apply to veterinarians.
11. Is a faxed prescription considered an electronic prescription?
No, a faxed prescription is not considered an electronic prescription. Electronic prescriptions must comply with the requirements in MCL 333.17754a(1) and (2).
12. Do I need to apply for a waiver if I qualify for an exemption under the law?
If you qualify for an exemption under MCL 333.17754a, you do not need to apply for a waiver. If you do make use of an exemption under the law, it is important to clearly document that information in the medical record.
13. Does a pharmacist need to verify that a prescriber has a waiver or qualifies under an exemption prior to filling a prescription that has not been electronically transmitted?
No. A pharmacist who receives a prescription that was not transmitted electronically to the pharmacy may dispense the prescription without determining whether an exception under MCL 333.17754a(5) applies.
If you have any additional questions, please contact BPL at 517-241-0199 or BPLHELP@michigan.gov.
Saginaw County Medical Society | Michigan State Medical Society
https://www.msms.org/About-MSMS/House-of-Delegates
Introduction
The House of Delegates (HOD) is the official policymaking body of the Michigan State Medical Society (MSMS). Resolutions and Board Action Reports are the vehicles used to debate and determine the policies, priorities and direction of MSMS during the ensuing 12 months and beyond. Therefore, a well-crafted resolution is essential in order to present the most effective case for those issues that are of importance and concern to you.
Resolutions are presented to the MSMS HOD by voting delegates on behalf of their county delegation, specialty society, ethnic medical society, MSMS membership section, or as individual delegates. In order to be considered as regular business of the HOD, resolutions must be submitted to
MSMS by 5 p.m. on either March 1 or the next business day
if March 1 falls on a Saturday or Sunday. Once received, resolutions are reviewed by MSMS staff for comparison to existing MSMS and AMA policy, legal considerations, and appropriate editing. They are then assigned numbers and referred to one of the six House reference committees or placed on the "Reaffirmation Calendar." All resolutions for which the “Resolved” state either MSMS or AMA existing policy will be placed on a "Reaffirmation Calendar" and voted upon at Sunday's session. A delegate can ask the Committee on Rules and Order of Business to extract a resolution from the Reaffirmation Calendar for referral to a reference committee. The Committee on Rules and Order of Business meets on Saturday morning prior to the opening of the House.
Please note, pursuant to adopted HOD Resolution 65-14,
any resolutions "submitted to the MSMS HOD that require action by the AMA may only be submitted by MSMS members that are also members of the AMA."
The reference committees are responsible for listening to testimony on the rationale and merits of the submitted resolutions, discussing the issues raised for and against resolutions, and making recommendations to the HOD on the fate of the resolutions.
Process
All resolutions are to be submitted online at http://www. msms.org/hod. To complete the online resolution form, simply fill out the required fields and hit the "submit" button. Persons completing the form will need to include the following information: • Name, email, telephone number, affiliated organization, and county of the original author • Resolution title • The name of the person introducing the resolution and for whom the resolution is being introduced • Resolution text • Fiscal information (if applicable) • Footnotes/Endnotes (if applicable)
Deadline
5 p.m. on March 1 (or the next business day if March 1 falls on a Saturday or Sunday)
Late Resolutions
Resolutions received after the deadline will be considered late resolutions and will be referred to the Committee on Rules and Order of Business which meets on Saturday morning.
continued from page 16
The Committee reviews any late resolutions on the following criteria: • Could the resolution have been submitted before the deadline? • Did new developments after the deadline justify the acceptance of the resolution? • Were there any extenuating circumstances? • Are there any other resolutions that cover the same logic? If the Committee on Rules and Order of Business agrees to accept a late resolution, the resolution will be immediately referred to one of the six reference committees for testimony and consideration later that morning. The final recommendation as to the resolution’s fate will be submitted to the House as part of the respective committee's report on Sunday. If the Committee on Rules and Order of Business does not accept a late resolution, a delegate may ask to have the resolution extracted from the Report of the Committee on Rules and Order of Business on Sunday morning and present his or her arguments before the Committee of the Whole. If the House concurs with the Committee on Rules and Order of Business's recommendation to not accept the late resolution, there is no further recourse and the resolution will not be considered.
Structure of a Resolution Title:
• Select a title that is brief and accurately reflects the action for which the resolution calls.
Body:
• Begin with the inclusion of one or more "whereas" statements. • "Whereas" statements explain why the resolution is needed, provide documentation in support of the resolution (i.e., data, statistics, references), and contribute to the general understanding of the subject matter. • "Whereas" statements lead into one or more "resolved" sections. • "Resolved" sections define the "ask" or intent of the resolution (e.g., the author’s desired action). • Because the HOD only adopts the "resolved" sections, each "resolved" section must be able to stand independent of the "whereas" statements. o Example of an improperly written "resolved"
statement, as the reader cannot readily identify the targeted issue(s), specific action requested, or to whom responsibility for acting upon the issue(s) is directed:
RESOLVED: That physicians need to know about the process and extent of diversion in the community and need to act as described above. o Example of a properly written "resolved"
statement in which the issue and "ask" are clearly stated:
RESOLVED: That MSMS actively educate physicians about the process and extent of prescribed opiate medication diversion in the community and urge the health care providers prescribing daily opiates in chronic pain patients to monitor those patients at a minimum with yearly quantitative urine drug screens.
Tips
Paying particular attention to the following will enhance your chances of drafting a successful resolution: • Ensure the accuracy of information presented in the resolution. • Determine whether the topic of the resolution is existing MSMS and/or AMA policy prior to submission. o MSMS policy can be searched and accessed by
clicking HERE
• MSMS policy manual addenda can be accessed
by clicking HERE
o AMA policy can be searched and accessed by
clicking HERE
• If the Resolved statement is already existing policy, the resolution will be placed on the "Reaffirmation Calendar." • If the Resolved statement is consistent with existing policy, specifically state the amendment you want to that policy. • If the Resolved statement is not consistent with existing policy, indicate that you want to replace the existing policy. • Ensure that the desired intent or "ask" is clear. • Consider whether the requested action is feasible (i.e., is it relevant to medicine and to what MSMS can reasonably affect).
continued on page 18
